| answer text |
<p>The Department continues to support awareness of Group B streptococcus, alongside
the wider international community.</p><p>Group B streptococcus is the leading cause
of bacterial infection in newborn babies. The Government has recognised there are
gaps in the evidence relating to this issue and the National Institute for Health
Research has commissioned a trial to compare the clinical and cost effectiveness of
universal screening compared with usual risk-based care, which will help to understand
more about the potential benefits and harms of this approach.</p><p>This is a large-scale
and ambitious trial, the results of which will be of interest to the United Kingdom
National Screening Committee and will form one piece of the developing evidence picture
to inform its future recommendations for screening for Group B streptococcus.</p><p>
</p><p> </p><p> </p><p> </p>
|
 |
